| PHARMING GRP EO-,01 |
| Niederlande |
| Gesundheit |
| NL0010391025 / A1H65A |
| PHGN (Frankfurt) |
| FRA:PHGN, ETR:PHGN, PHGN:GR |
| - |
| https://www.pharming.com/ |
|
Pharming Group N.V. is a global biopharmaceutical company specializing in the development and commercialization of innovative protein replacement therapies and precision medicines for rare, debilitating, and life-threatening diseases. Its lead produc..
>Volltext.. |
| 658.27 Mio. EUR |
| 630.63 Mio. EUR |
| 313.71 Mio. EUR |
| 29.5 Mio. EUR |
| 7.88 Mio. EUR |
| 0.01 EUR |
| 110.67 Mio. EUR |
| 138.2 Mio. EUR |
| 22.96 Mio. EUR |
| 1.7 |
| 0.59% |
| - |
| - |
| - |
| - |
| - |
| PHARMING |
| 23.09.26 |
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|